TOPIC

MDMA by monnica williams

Below are the best resources we could find on MDMA featuring monnica williams.

FindCenter Video Image
29:57

Marginalized Voices, Racial Trauma, and the Psychedelic Healing Movement

Monnica T. Williams, Ph.D., ABPP, is an Associate Professor in the School of Psychology at the University of Ottawa, Canada Research Chair in Mental Health Disparities, and Director of the Laboratory for Culture and Mental Health Disparities.

FindCenter AddIcon
FindCenter Video Image

Who Will Benefit From Psychedelic Medicine?

These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all.

FindCenter AddIcon
FindCenter Video Image
41:30

Horizons 2018: Monnica Williams Ph.D. on “Race-Based Trauma”

“Race-Based Trauma: The Challenge and Promise of MDMA-Assisted Psychotherapy” Monnica Williams, Ph.D.

FindCenter AddIcon
FindCenter Video Image

Psychedelic Drugs Can Help Treat PTSD Caused by Racism, Discrimination: Researchers

Williams is the co-lead author of a recent retrospective study that found those who tried doses of psilocybin (more commonly known as magic mushrooms), LSD, or MDMA (the pure substance found in Ecstasy or Molly) reported a decrease in trauma symptoms, depression and anxiety after 30 days.

FindCenter AddIcon
FindCenter Video Image
19:59

Episode 13 - Dr. Williams: Psychedelics and Mental Health | Chatting in the City

Dr. Monnica Williams is a professor, clinical psychologist, and the Canada Research Chair for Mental Health Disparities at the University of Ottawa.  

FindCenter AddIcon
FindCenter Video Image

Psychedelic Therapy and Racial Trauma: Offering Clients a Deeper Experience of Healing

Like most people of color in the United States, psychotherapist and researcher Monnica Williams has experienced myriad forms of racism. Early in her career, understanding its effects on her mind and body motivated her to help clients address their own racial trauma in therapy.

FindCenter AddIcon
FindCenter Video Image

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

FindCenter AddIcon
FindCenter Video Image

Experimental Treatments Changed the Course of the AIDS Epidemic; We Need the Same Approach to Mental Illness Today | Commentary

Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.

FindCenter AddIcon
FindCenter Video Image
44:17

Monnica Williams: The Experience of Racism Is an Assault on Mental Health

My guest on the show today is Dr. Monnica T. Williams, certified licensed clinical psychologist and Associate Professor at the School of Psychology at the University of Ottawa. Monnica is researching how PTSD symptoms can result from racism and what racial trauma and race-based trauma look like.

FindCenter AddIcon
FindCenter Video Image

The Cost of Exclusion in Psychedelic Research

In the last two decades, researchers have started to reexamine psychedelics for their therapeutic potential. Though initial results seem promising, the research has a significant shortcoming: the lack of racial and ethnic diversity among research teams and study participants.

FindCenter AddIcon

UP NEXT

Psychedelic-Assisted Therapy